Home Casteddu.com FAQ My Amedeo About Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Gynecology

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 553 articles:
HTML format

Single Articles


    July 2009
  1. BERCHUCK A
    Microarray analysis of gene expression in gynecologic cancers--still only the beginning.
    Gynecol Oncol. 2009;114:1-2.
    PubMed     Related articles   


    June 2009
  2. SFAKIANOS GP , Numnum TM, Halverson CB, Panjeti D, et al
    The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  3. PANDEY S , Mittal RD, Srivastava M, Srivastava K, et al
    Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  4. FULHAM MJ , Carter J, Hicks R
    The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project: Response to a letter from Dr. Maure Markman.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  5. RADES D , Fischer D, Veninga T, Stalpers LJ, et al
    Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  6. SERT MB
    Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  7. OH JH , Kim JH, Ahn HJ, Yoon JH, et al
    Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  8. TAO X , Sood AK, Deavers MT, Schmeler KM, et al
    Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  9. DARCY KM , Brady WE, Blancato JK, Dickson RB, et al
    Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  10. SEAMON LG , Downey GO, Harrison CR, Doss B, et al
    Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  11. BACKES FJ , Leon ME, Ivanov I, Suarez A, et al
    Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  12. POWER P , Stuart G, Oza A, Provencher D, et al
    Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  13. KAPNICK J , Helgason H
    Indefinitely prolonged survival after relapse in advanced ovarian cancer: The other end of the telescope.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  14. SMITH HO , Arias-Pulido H, Kuo DY, Howard T, et al
    GPR30 predicts poor survival for ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  15. JIMENEZ W , Paszat L, Kupets R, Wilton A, et al
    Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  16. HU X , Macdonald DM, Huettner PC, Feng Z, et al
    A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  17. STITT IA , Stany MP, Moser RP 3rd, Rose GS, et al
    Incidental gynecological findings on computed tomographic colonography: Prevalence and outcomes.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  18. WENZEL L
    Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step?
    Gynecol Oncol. 2009;113:299-300.
    PubMed     Related articles   


  19. EIJSINK JJ , de Bock GH, Kuiper JL, Reesink-Peters N, et al
    Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ).
    Gynecol Oncol. 2009;113:348-51.
    PubMed     Related articles    Abstract available


  20. OONK MH , van Os MA, de Bock GH, de Hullu JA, et al
    A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy.
    Gynecol Oncol. 2009;113:301-5.
    PubMed     Related articles    Abstract available


  21. ZHANG W , Peng Z, Xu L
    Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review.
    Gynecol Oncol. 2009;113:399-401.
    PubMed     Related articles    Abstract available


  22. FOLKINS AK , Jarboe EA, Roh MH, Crum CP, et al
    Precursors to pelvic serous carcinoma and their clinical implications.
    Gynecol Oncol. 2009;113:391-6.
    PubMed     Related articles    Abstract available


  23. MOORE DH
    Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?
    Gynecol Oncol. 2009;113:379-83.
    PubMed     Related articles    Abstract available


    May 2009
  24. BRISTOW RE , Peiretti M, Gerardi M, Zanagnolo V, et al
    Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: Operative technique and clinical outcome.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  25. ZHOU X , Han S, Wang S, Chen X, et al
    Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  26. MARKMAN M
    The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  27. KURDOGLU M , Bayram I, Kolusari A, Erten R, et al
    Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  28. WU TI , Lee CL, Wu MY, Hsueh S, et al
    Prognostic factors predicting recurrence in borderline ovarian tumors.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  29. HARIRI LP , Bonnema GT, Schmidt K, Winkler AM, et al
    Laparoscopic optical coherence tomography imaging of human ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  30. MIRABEAU-BEALE KL , Kornblith AB, Penson RT, Lee H, et al
    Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  31. FADER AN , Escobar PF
    Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: Technique and initial report.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  32. RAHKOLA P , Mikkola TS, Ylikorkala O, Vaisanen-Tommiska M, et al
    Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  33. MORGAN J , Hoekstra AV, Chapman-Davis E, Hardt JL, et al
    Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  34. MCMEEKIN DS , Lisyanskaya A, Crispens M, Oza AM, et al
    Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  35. SMITH HO , Moon J, Wilczynski SP, Tiersten AD, et al
    Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  36. LURIE G , Thompson PJ, McDuffie KE, Carney ME, et al
    Prediagnostic symptoms of ovarian carcinoma: A case-control study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  37. LEVENBACK CF , van der Zee AG, Rob L, Plante M, et al
    Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  38. FOTIOU S , Aliki T, Petros Z, Ioanna S, et al
    Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  39. WANG L , Madigan MC, Chen H, Liu F, et al
    Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  40. ROCCONI RP , Matthews KS, Kemper MK, Hoskins KE, et al
    The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  41. MARKMAN M , Liu PY, Moon J, Monk BJ, et al
    Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m(2)) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic On
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  42. ALTGASSEN C , Muller N, Hornemann A, Kavallaris A, et al
    Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  43. LANDRUM LM , McMeekin DS
    Response to "Residual tumor after neoadjuvant chemotherapy and interval debulking for advanced endometrial cancer"
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  44. HOEKSTRA AV , Morgan JM, Lurain JR, Buttin BM, et al
    Robotic surgery in gynecologic oncology: Impact on fellowship training.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  45. TANYI JL , Smith JA, Ramos L, Parker CL, et al
    Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  46. BRICOU A , Barranger E, Uzan S, Darai E, et al
    Anaphylactic shock during the sentinel lymph node procedure for cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  47. YU KJ , Rader JS, Borecki I, Zhang Z, et al
    CD83 polymorphisms and cervical cancer risk.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  48. HAVRILESKY LJ , Secord AA, O'Malley DM, Broadwater G, et al
    Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  49. KANG H , Kim TJ, Lee YY, Choi CH, et al
    Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  50. SAFRA T , Menczer J, Bernstein RM, Shpigel S, et al
    Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  51. KIZER NT , Zighelboim I, Case AS, Dewdney SB, et al
    The role of PET/CT in the management of patients with cervical cancer: Practice patterns of the members of the Society of Gynecologic Oncologists.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  52. EITAN R , Kushnir M, Lithwick-Yanai G, David MB, et al
    Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  53. FARGHALY SA
    Observation on the surgical aspect of resection of noncolorectal nonneuroendocrine hepatic parenchymal metastasis in patients with primary epithelial ovarian carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  54. MEIER W , du Bois A, Reuss A, Kuhn W, et al
    Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekolo
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  55. SEAMON LG , Fowler JM, Richardson DL, Carlson MJ, et al
    A detailed analysis of the learning curve: Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  56. HOEKSTRA AV , Kim RJ, Small W Jr, Rademaker AW, et al
    FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  57. UBERTI EM , Fajardo MD, da Cunha AG, Rosa MW, et al
    Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: A simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  58. SATO T , Ota T, Watanabe M, Imada K, et al
    Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  59. LOWE KA , Andersen MR, Urban N, Paley P, et al
    The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  60. PEEDICAYIL A , Vierkant RA, Shridhar V, Schildkraut JM, et al
    Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  61. GOODFELLOW PJ
    Clinicopathologic significance of DNA mismatch repair defects in endometrial cancer: the devil is in the details.
    Gynecol Oncol. 2009;113:151-2.
    PubMed     Related articles   


  62. FRANCHELLI S , Leone MS, Bruzzone M, Muggianu M, et al
    The gluteal fold fascio-cutaneous flap for reconstruction after radical excision of primary vulvar cancers.
    Gynecol Oncol. 2009;113:245-8.
    PubMed     Related articles    Abstract available


  63. TAN W , Stehman FB, Carter RL
    Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  64. DE JONG RA , Leffers N, Boezen HM, Ten Hoor KA, et al
    Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


    April 2009
  65. CHIEN J , Fan JB, Bell DA, April C, et al
    Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  66. MASSAD LS , Einstein M, Myers E, Wheeler CM, et al
    The impact of human papillomavirus vaccination on cervical cancer prevention efforts.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  67. NAUMANN RW , Sukumvanich P, Edwards RP
    Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  68. RICHTER CE , Qian B, Martel M, Yu H, et al
    Ovarian preservation and staging in reproductive-age endometrial cancer patients.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  69. BROOKS RA , Wright JD, Powell MA, Rader JS, et al
    Long-term assessment of bladder and bowel dysfunction after radical hysterectomy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  70. NOYES N , Abu-Rustum NR, Ramirez PT, Plante M, et al
    Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  71. BOSE CK
    Is randomized trial of neoadjuvant chemotherapy of ovarian cancer necessary?
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  72. O'MEARA AC , Giger OT, Kurrer M, Schaer G, et al
    Case report: Recurrence of a uterine tumor resembling ovarian sex-cord tumor.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  73. FADER AN , Arriba LN, Frasure HE, von Gruenigen VE, et al
    Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  74. LUPE K , D'Souza DP, Kwon JS, Radwan JS, et al
    Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  75. TSAI-TURTON M , Santillan A, Lu D, Bristow RE, et al
    p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  76. AMANT F , Despierre E, Vandenput I
    Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  77. KASAMATSU T , Onda T, Sawada M, Kato T, et al
    Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  78. MARKMAN M
    In response to: "Towards randomized trials of peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis"
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  79. LAN C , Li Y, Liu J
    Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  80. SEPPO A , Jalali GR, Babkowski R, Symiakaki H, et al
    Gain of 3q26: A genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  81. GHAMANDE SA , Silverman M, Gold M
    A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  82. CHI DS , Eisenhauer EL, Zivanovic O, Sonoda Y, et al
    Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  83. FERGUSON SE , Malhotra T, Seshan VE, Levine DA, et al
    A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  84. RESNICK KE , Hampel H, Fishel R, Cohn DE, et al
    Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  85. CAI KQ , Wu H, Klein-Szanto AJ, Xu XX, et al
    Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  86. PALOMBA S , Falbo A, Russo T, Zullo F, et al
    Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  87. CHUA TC , Liauw W, Robertson G, Chia WK, et al
    Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  88. GERSHENSON DM , Sun CC, Bodurka D, Coleman RL, et al
    Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  89. FENNIMORE IA , Simon NL, Bills G, Dryfhout VL, et al
    Extension of ovarian tissue into the infundibulopelvic ligament beyond visual margins.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  90. LI J , Jia H, Xie L, Wang X, et al
    Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  91. SCHWARTZ J , Toste B, Dizon DS
    Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m(2).
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  92. ALAM SM , Fujimoto J, Jahan I, Sato E, et al
    Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  93. FENG F , Xiang Y, Li L, Wan X, et al
    Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  94. ESTAPE R , Lambrou N, Diaz R, Estape E, et al
    A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  95. TIRO AV , Talukdar R, Lewis MG
    A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  96. FAGOTTI A , Paris I, Grimolizzi F, Fanfani F, et al
    Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  97. OREZZOLI JP , Sioletic S, Olawaiye A, Oliva E, et al
    Stage II endometrioid adenocarcinoma of the endometrium: Clinical implications of cervical stromal invasion.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available



  98. Hereditary breast and ovarian cancer syndrome.
    Gynecol Oncol. 2009;113:6-11.
    PubMed     Related articles   


  99. MONK BJ , Ali S, Gaffney DK
    When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer.
    Gynecol Oncol. 2009;113:1-3.
    PubMed     Related articles   


  100. SEAMON LG , Holt CN, Suarez A, Richardson DL, et al
    Paratubal borderline serous tumors.
    Gynecol Oncol. 2009;113:83-5.
    PubMed     Related articles    Abstract available


  101. SPINILLO A , Dal Bello B, Gardella B, Roccio M, et al
    Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Gynecol Oncol. 2009;113:115-9.
    PubMed     Related articles    Abstract available


  102. ISMIIL N , Ghorab Z, Covens A, Nofech-Mozes S, et al
    Intraoperative margin assessment of the radical trachelectomy specimen.
    Gynecol Oncol. 2009;113:42-6.
    PubMed     Related articles    Abstract available


  103. MATOVINA M , Sabol I, Grubisic G, Gasperov NM, et al
    Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
    Gynecol Oncol. 2009;113:120-7.
    PubMed     Related articles    Abstract available


  104. MAGRINA JF , Kho R, Montero RP, Magtibay PM, et al
    Robotic extraperitoneal aortic lymphadenectomy: Development of a technique.
    Gynecol Oncol. 2009;113:32-5.
    PubMed     Related articles    Abstract available


  105. TRIMBOS JB
    TNM-like classification of radical hysterectomy.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  106. GERESTEIN CG , Damhuis RA, Burger CW, Kooi GS, et al
    Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


    March 2009
  107. GUNTUPALLI SR , Ramirez PT, Anderson ML, Milam MR, et al
    Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  108. ANSENBERGER K , Zhuge Y, Lagman JA, Richards C, et al
    E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  109. DANN JM , Sykes PH, Mason DR, Evans JJ, et al
    Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  110. GUPTA D , Owers RL, Kim M, Kuo DY, et al
    A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  111. KARAM AK , Chiang JW, Fung E, Nossov V, et al
    Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  112. ARABI H , Guan H, Kumar S, Cote M, et al
    Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  113. SHIMADA M , Kigawa J, Ohishi Y, Yasuda M, et al
    Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  114. FARLEY J , Fuchiuji S, Darcy KM, Tian C, et al
    Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  115. HAYES MP , Douglas W, Ellenson LH
    Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  116. EL-HELW LM , Coleman RE, Everard JE, Tidy JA, et al
    Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  117. TINELLI R , Cicinelli E, Tinelli A, Malzoni M, et al
    Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  118. MABUCHI S , Morishige K, Fujita M, Tsutsui T, et al
    The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  119. SANTOSO JT , Azadi A, Wan J, Handorf C, et al
    Lymph node counts in uterine cancer: A randomized double blind trial.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  120. PLUTA M , Rob L, Charvat M, Chmel R, et al
    Less radical surgery than radical hysterectomy in early stage cervical cancer - A pilot study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  121. SCHMELER KM , Vadhan-Raj S, Ramirez PT, Apte SM, et al
    A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  122. BEGUM FD , Hogdall E, Kjaer SK, Blaakaer J, et al
    Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  123. WALKER JL
    Intraperitoneal chemotherapy for ovarian cancer: 2009 goals.
    Gynecol Oncol. 2009;112:439-40.
    PubMed     Related articles   


  124. ENGLE DB , Belisle JA, Gubbels JA, Petrie SE, et al
    Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.
    Gynecol Oncol. 2009;112:631-6.
    PubMed     Related articles    Abstract available


  125. ZIVANOVIC O , Leitao MM Jr, Park KJ, Zhao H, et al
    Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Gynecol Oncol. 2009;112:590-3.
    PubMed     Related articles    Abstract available


  126. RYU HS
    Asian Society of Gynecologic Oncology (ASGO): A new society for doctors working against gynecologic cancers in Asia.
    Gynecol Oncol. 2009;112:442-3.
    PubMed     Related articles   


    February 2009
  127. KEHOE SM , Williams NL, Yakubu R, Levine DA, et al
    Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  128. ALVAREZ EA , Wolfson AH, Pearson JM, Crisp MP, et al
    A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  129. OLAWAIYE AB , Boruta D
    Management of women with clear cell endometrial cancer A Society of Gynecologic Oncology (SGO) review.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  130. JACOBSON G , Lammli J, Zamba G, Hua L, et al
    Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  131. PERSSON J , Reynisson P, Borgfeldt C, Kannisto P, et al
    Robot assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy with short and long term morbidity data.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  132. LOWE MP , Chamberlain DH, Kamelle SA, Johnson PR, et al
    A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  133. KUMAR S , Shah JP, Bryant CS, Awonuga AO, et al
    Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  134. GHEZZI F , Cromi A, Siesto G, Zefiro F, et al
    Microlaparoscopy: A further development of minimally invasive surgery for endometrial cancer staging - Initial experience.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  135. LEFFERS N , Gooden MJ, Mokhova AA, Kast WM, et al
    Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  136. ARGENTA PA , Thomas SG, Judson PL, Downs LS Jr, et al
    A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  137. BOREN T , Xiong Y, Hakam A, Wenham R, et al
    MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  138. YAMADA T , Mori H, Kanemura M, Ohmichi M, et al
    Endometrial carcinoma with choriocarcinomatous differentiation: A case report and review of the literature.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  139. ABU-RUSTUM NR , Khoury-Collado F, Pandit-Taskar N, Soslow RA, et al
    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  140. PERRONE AM , Meriggiola MC, Pelusi G
    Sentinel node of endometrial cancer after hysteroscopic injection.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  141. FREDERICK PJ , Straughn JM Jr, Alvarez RD, Buchsbaum DJ, et al
    Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  142. KURTZ JE , Hardy-Bessard AC, Deslandres M, Lavau-Denes S, et al
    Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  143. DAVID MP , Van Herck K, Hardt K, Tibaldi F, et al
    Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  144. HAVRILESKY LJ , Broadwater G, Davis DM, Nolte KC, et al
    Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  145. CANNON GM , Geye H, Terakedis BE, Kushner DM, et al
    Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  146. TAKAHASHI A , Kato K, Kuboyama A, Inoue T, et al
    Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  147. KIM HS , Kim MK, Chung HH, Kim JW, et al
    Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  148. BERRY E , Matthews KS, Singh DK, Buttin BM, et al
    An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  149. ASHTON KA , Proietto A, Otton G, Symonds I, et al
    Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  150. KLASA-MAZURKIEWICZ D , Narkiewicz J, Milczek T, Lipinska B, et al
    Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  151. STEHMAN FB , Ali S, Disaia PJ
    Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available



  152. Abstracts presented for the 40th Annual Meeting of the Society of Gynecologic Oncologists,San Antonio, Texas, USA,05-08 February 2009.
    Gynecol Oncol. 2009;112.
    PubMed     Related articles   


  153. NEPHEW KP
    What will it take to obtain DNA methylation markers for early cervical cancer detection?
    Gynecol Oncol. 2009;112:291-2.
    PubMed     Related articles   


  154. MATULONIS UA , Krag KJ, Krasner CN, Atkinson T, et al
    Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors.
    Gynecol Oncol. 2009;112:394-9.
    PubMed     Related articles    Abstract available


    January 2009
  155. ONDA T , Kobayashi H, Nakanishi T, Hatae M, et al
    Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  156. YANG XY , Xi MR, Yang KX, Yu H, et al
    Prognostic value of estrogen receptor and progesterone receptor status in Chinese young ovarian carcinoma patients.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  157. MICHELSEN TM , Dorum A, Dahl AA
    A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  158. MARKMAN M
    Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  159. MAGRINA JF , Kho R, Magtibay PM
    Robotic radical hysterectomy: Technical aspects.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  160. GREVING JP , Vernooij F, Heintz AP, van der Graaf Y, et al
    Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  161. CHIVA LM , Lapuente F, Nunez C, Ramirez PT, et al
    Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  162. PARK JY , Kim DY, Kim JH, Kim YM, et al
    Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  163. QUINN JE , Carser JE, James CR, Kennedy RD, et al
    BRCA1 and implications for response to chemotherapy in ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  164. SEAMON LG , Cohn DE, Henretta MS, Kim KH, et al
    Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  165. LEITAO MM JR , Kehoe S, Barakat RR, Alektiar K, et al
    Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  166. LECURU F , Bats AS, Faraggi M
    Sentinel node of endometrial cancer after hysteroscopic injection.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  167. BROWN J , Sood AK, Deavers MT, Milojevic L, et al
    Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  168. SCHILDER RJ , Pathak HB, Lokshin AE, Holloway RW, et al
    Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  169. PIERLUIGI BP , Stefano B, Roberto A
    Pelvic and aortic lymphadenectomy in cervical cancer: The standardization of surgical procedure and its clinical impact.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  170. BEERMAN H , van Dorst EB, Kuenen-Boumeester V, Hogendoorn PC, et al
    Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  171. HOYER PB , Davis JR, Bedrnicek JB, Marion SL, et al
    Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  172. BIJEN CB , de Bock GH, Mourits MJ
    Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study.
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  173. LEE YK , Park NH
    Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  174. FULHAM MJ , Carter J, Baldey A, Hicks RJ, et al
    The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  175. HEUBNER M , Riemann K, Otterbach F, Kimmig R, et al
    The haplotype of two FSHR polymorphisms in ovarian cancer- A potential role of ethnology in risk modification.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  176. MCLEAN K , Vandeven NA, Sorenson DR, Daudi S, et al
    The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  177. WATTS LA , Joseph N, Wallace M, Rauh-Hain JA, et al
    HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  178. NEUBAUER NL , Havrilesky LJ, Calingaert B, Bulusu A, et al
    The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  179. FANG CY , Cherry C, Devarajan K, Li T, et al
    A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  180. MABROUK M , Frumovitz M, Greer M, Sharma S, et al
    Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  181. MARKMAN M
    "A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer"
    Gynecol Oncol. 2009.
    PubMed     Related articles   


  182. TIERSTEN AD , Liu PY, Smith HO, Wilczynski SP, et al
    Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  183. VERNOOIJ F , Heintz AP, Coebergh JW, Massuger LF, et al
    Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in The Netherlands.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  184. FEHM T , Beck V, Banys M, Lipp HP, et al
    Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  185. RUBATT JM , Darcy KM, Hutson A, Bean SM, et al
    Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  186. BIJEN CB , de Bock GH, Ten Hoor KA, Nijman HW, et al
    Role of endocervical curettage in the preoperative staging of endometrial carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  187. SHIELD K , Ackland ML, Ahmed N, Rice GE, et al
    Multicellular spheroids in ovarian cancer metastases: Biology and pathology.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  188. CHIN SN , Pinto V, Rosen B, Oza A, et al
    Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  189. HENSLEY ML , Ishill N, Soslow R, Larkin J, et al
    Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  190. FOWLER JM , Brady WE, Grigsby PW, Cohn DE, et al
    Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A gynecologic oncology group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  191. SHETH RA , Upadhyay R, Stangenberg L, Sheth R, et al
    Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  192. OLAWAIYE A , Del Carmen M, Tambouret R, Goodman A, et al
    Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice.
    Gynecol Oncol. 2009.
    PubMed     Related articles    Abstract available


  193. CHI DS , Zivanovic O, Palayekar MJ, Eisenhauer EL, et al
    A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Gynecol Oncol. 2009;112:6-10.
    PubMed     Related articles    Abstract available


  194. BRISTOW RE
    Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen.
    Gynecol Oncol. 2009;112:1-3.
    PubMed     Related articles   


  195. VORGIAS G , Iavazzo C, Savvopoulos P, Myriokefalitaki E, et al
    Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study.
    Gynecol Oncol. 2009;112:11-5.
    PubMed     Related articles    Abstract available


  196. CAMPANER AB , Longo Galvao MA
    Application of an easy and useful morphometric technique for immunohistochemistry counting.
    Gynecol Oncol. 2009;112:282-3.
    PubMed     Related articles   


  197. KUMAR S , Shah JP, Malone JM Jr
    Vulvar cancer in women less than fifty in United States, 1980-2005.
    Gynecol Oncol. 2009;112:283-4.
    PubMed     Related articles   


    December 2008
  198. FADER AN , Nagel C, Axtell AE, Zanotti KM, et al
    Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  199. FOTIOU S , Vlahos N, Kondi-Pafiti A, Zarganis P, et al
    Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  200. DEVETZI M , Scorilas A, Tsiambas E, Sameni M, et al
    Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  201. RANDALL LM , Monk BJ, Darcy KM, Tian C, et al
    Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  202. WILLIAMS SJ , Cvetkovic D, Hamilton TC
    Vitamin A metabolism is impaired in human ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  203. WHITWORTH JM , Matthews KS, Shipman KA, Numnum TM, et al
    The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  204. HOMESLEY HD , Filiaci V, Gibbons SK, Long HJ, et al
    A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  205. BRAGA A , Maesta I, Michelin OC, Delmanto LR, et al
    Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  206. JONGEN V , Briet J, de Jong R, Ten Hoor K, et al
    Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  207. CAMUZCUOGLU H , Arioz DT, Toy H, Kurt S, et al
    Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  208. KARAM AK , Stempel M, Barakat RR, Morrow M, et al
    Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  209. CHUNG MT , Lai HC, Sytwu HK, Yan MD, et al
    SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  210. HAVRILESKY LJ , Maxwell GL, Chan JK, Myers ER, et al
    Cost effectiveness of a test to detect metastases for endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  211. KEHOE SM , Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al
    Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  212. VIJAYARAGHAVAN A , Efrusy M, Lindeque G, Dreyer G, et al
    Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  213. BALLESTER M , Rouzier R, Coutant C, Kerrou K, et al
    Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  214. ASHING-GIWA KT , Tejero JS, Kim J, Padilla GV, et al
    Cervical cancer survivorship in a population based sample.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  215. ATMACA A , Al-Batran SE, Neumann A, Kolassa Y, et al
    Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - A phase II study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  216. FOX KA
    Relative mortality in the women over 60 years of age with cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  217. GROWDON WB , Wolfberg AJ, Goldstein DP, Feltmate CM, et al
    Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  218. MATTHEWS KS , Straughn JM Jr, Kemper MK, Hoskins KE, et al
    The effect of obesity on survival in patients with ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  219. FUJIMOTO T , Nanjyo H, Fukuda J, Nakamura A, et al
    Endometrioid uterine cancer: Histopathological risk factors of local and distant recurrence.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  220. WENTZENSEN N , Sherman ME, Schiffman M, Wang SS, et al
    Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  221. YANG GF , Xie D, Liu JH, Luo JH, et al
    Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  222. CHI DS , Schwartz PE
    Cytoreduction vs. neoadjuvant chemotherapy for ovarian cancer.
    Gynecol Oncol. 2008;111:391-9.
    PubMed     Related articles   


  223. RUBIN SC
    Maintenance of certification in obstetrics and gynecology: The time has come.
    Gynecol Oncol. 2008;111:389-90.
    PubMed     Related articles   


  224. GILANI MM , Karimi Zarchi M, Ghaemmaghami F, Behtash N, et al
    Retraction notice to "A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer" [Gynecol. Oncol. 105 (2007) 780-783].
    Gynecol Oncol. 2008;111:516.
    PubMed     Related articles   


  225. BORONOW RC
    Fallopian tube cancer: radical surgery, extended field radiation and chemotherapy in 24 personal cases treated with "intent to cure".
    Gynecol Oncol. 2008;111:517-22.
    PubMed     Related articles    Abstract available


  226. PERSSON J , Kannisto P, Bossmar T
    Robot-assisted abdominal laparoscopic radical trachelectomy.
    Gynecol Oncol. 2008;111:564-7.
    PubMed     Related articles    Abstract available


  227. ONUJIOGU N , Lengyel E, Yamada SD
    Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
    Gynecol Oncol. 2008;111:537-9.
    PubMed     Related articles    Abstract available


  228. SCHONMAN R , Klein Z, Edelstein E, Czernobilsky B, et al
    Luteinized thecoma associated with sclerosing peritonitis--conservative surgical approach followed by corticosteroid and GnRH agonist treatment--a case report.
    Gynecol Oncol. 2008;111:540-3.
    PubMed     Related articles    Abstract available


  229. KIM S , Anderson L, Silberzweig JE
    Endovascular graft placement for femoral artery erosion caused by recurrent vulvar carcinoma.
    Gynecol Oncol. 2008;111:572-4.
    PubMed     Related articles    Abstract available


  230. SEAMON LG , Richardson DL, Pierce M, O'Malley DM, et al
    Local correction of extreme stomal prolapse following transverse loop colostomy.
    Gynecol Oncol. 2008;111:549-51.
    PubMed     Related articles    Abstract available


  231. BRYANT CS , Shah JP, Triest JA, Schimp VL, et al
    Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.
    Gynecol Oncol. 2008;111:552-4.
    PubMed     Related articles    Abstract available


  232. KARAM A , Berek JS, Stenson A, Rao J, et al
    HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
    Gynecol Oncol. 2008;111:568-71.
    PubMed     Related articles    Abstract available


    November 2008
  233. LANDRUM LM , Moore KN, Myers TK, Lanneau GS Jr, et al
    Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  234. BERRY E , Hardt JL, Clardy J, Lurain JR, et al
    Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  235. MENNINI FS , Giorgi Rossi P, Palazzo F, Largeron N, et al
    Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  236. CHUNG MT , Sytwu HK, Yan MD, Shih YL, et al
    Promoter methylation of SFRPs gene family in cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  237. HUANG YH , Zhao XJ, Zhang QH, Xin XY, et al
    The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  238. COKER AL , Desimone CP, Eggleston KS, Hopenhayn C, et al
    Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995-2005.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  239. ALETTI GD , Podratz KC, Moriarty JP, Cliby WA, et al
    Aggressive and complex surgery for advanced ovarian cancer: An economic analysis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  240. CHEN LL , Ye F, Yu Y, Chen HZ, et al
    Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  241. ALEKTIAR KM , Makker V, Abu-Rustum NR, Soslow RA, et al
    Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  242. METCALFE KA , Fan I, McLaughlin J, Risch HA, et al
    Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  243. MITCHELL DG , Snyder B, Coakley F, Reinhold C, et al
    Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  244. HOPE JM , Wang FQ, Whyte JS, Ariztia EV, et al
    LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  245. TANGJITGAMOL S , Manusirivithaya S, Laopaiboon M, Lumbiganon P, et al
    Interval debulking surgery for advanced epithelial ovarian cancer: A Cochrane systematic review.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  246. WALKER JL , Morrison A, Disilvestro P, von Gruenigen VE, et al
    A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: A gynecologic oncology group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  247. LIM MC , Kang S, Lee KS, Han SS, et al
    The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  248. VAN DE LANDE J , Davelaar EM, von Mensdorff-Pouilly S, Water TJ, et al
    SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  249. MULLER CY , Cole LA
    The quagmire of hCG and hCG testing in gynecologic oncology.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  250. WATARI H , Xiong Y, Hassan MK, Sakuragi N, et al
    Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  251. HO CM , Lin MC, Huang SH, Huang CJ, et al
    PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  252. NOLEN B , Marrangoni A, Velikokhatnaya L, Prosser D, et al
    A serum based analysis of ovarian epithelial tumorigenesis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  253. ANDERSON NS , Bermudez Y, Badgwell D, Chen R, et al
    Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  254. ZHU X , Lv J, Yu L, Zhu X, et al
    Proteomic identification of differentially-expressed proteins in squamous cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  255. DE MARCHI TRIGLIA R , Metze K, Zeferino LC, Lucci De Angelo Andrade LA, et al
    HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  256. INGERSOLL SB , Patel S, Caballero L, Ahmad S, et al
    Synergistic cytotoxicity of interferonalpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  257. DU BOIS A , Rochon J, Pfisterer J, Hoskins WJ, et al
    Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  258. MORICE P , Uzan C, Gouy S, Pautier P, et al
    Results of conservative treatment of epithelial ovarian tumor.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  259. URICK ME , Giles JR, Johnson PA
    Dietary aspirin decreases the stage of ovarian cancer in the hen.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available



  260. The second edition of the Society of Gynecologic Oncologists Surgical Postgraduate Courses supplement from the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa, Florida, USA, March 9-12, 2008.
    Gynecol Oncol. 2008;111.
    PubMed     Related articles   


  261. ROBINSON W , Ritter J, Rogers A, Tedjarati S, et al
    Participation in clinical research is associated with improved survival in women with ovarian cancer.
    Gynecol Oncol. 2008;111:386.
    PubMed     Related articles   


  262. CHASE DM , Kang S, Huang Y, Tewari KS, et al
    Hormone replacement therapy (HRT) is associated with improved survival among young women with epithelial ovarian carcinoma (EOC).
    Gynecol Oncol. 2008;111:386.
    PubMed     Related articles   


  263. RAJ M , Abd Elmageed Z, Zhou J, Gaur RL, et al
    Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.
    Gynecol Oncol. 2008;111:385.
    PubMed     Related articles   


  264. YU X , Cohen J, Deshmukh H, Zhang R, et al
    The association of serial ultrasounds and CA125 prior to diagnosis of ovarian cancer-Do they improve early detection?
    Gynecol Oncol. 2008;111:385-6.
    PubMed     Related articles   


  265. ABIDI A , Xing G, Nasseri K, Cress R, et al
    Age and race disparity in incidence, treatment and survival of cervical cancer in California.
    Gynecol Oncol. 2008;111:384.
    PubMed     Related articles   


  266. CONNOR J , Felder M
    Ascites from epithelial ovarian cancer contains high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance and poor patient outcome.
    Gynecol Oncol. 2008;111:384-5.
    PubMed     Related articles   


  267. WANG-CHESEBRO A , Kim D, Pouliot J, Chen LM, et al
    Initial clinical report of high dose rate brachytherapy boost using inverse planning simulated annealing (IPSA) for locoregionally advanced cervical cancer.
    Gynecol Oncol. 2008;111:383.
    PubMed     Related articles   


  268. DELIC L , Cass I, Li A, Leuchter R, et al
    Brachytherapy versus external beam radiation therapy in high intermediate risk endometrial cancer patients.
    Gynecol Oncol. 2008;111:383-4.
    PubMed     Related articles   


  269. URBAN R , Deshmukh H, Zhang R, Yu X, et al
    The impact of chemotherapy on the survival of early-stage I-II epithelial ovarian cancer.
    Gynecol Oncol. 2008;111:382.
    PubMed     Related articles   


  270. SCHMELER KM , Jhingran A, Iyer RB, Sun CC, et al
    Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors.
    Gynecol Oncol. 2008;111:382.
    PubMed     Related articles   


  271. ELFRINK SH , Myers TK, Gold MA, Walker JL, et al
    Chemotherapy in recurrent ovarian cancer: What clinical benefit should be expected?
    Gynecol Oncol. 2008;111:380.
    PubMed     Related articles   


  272. CHASE DM , Rincon A, Deane M, Tewari KS, et al
    Socioeconomic factors may contribute to the poor prognosis observed among women with advanced ovarian carcinoma treated with neoadjuvant chemotherapy.
    Gynecol Oncol. 2008;111:380-1.
    PubMed     Related articles   


  273. PENNER K , Dorigo O, Walsh C, Cass I, et al
    Multi-institutional study identifying predictors of response to progestin treatment of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma.
    Gynecol Oncol. 2008;111:379.
    PubMed     Related articles   


  274. DESHMUKH H , Zhang R, Yu X, Shin JY, et al
    The effect of gynecologic oncologists on the survival of endometrial cancer patients.
    Gynecol Oncol. 2008;111:379-80.
    PubMed     Related articles   


  275. IOFFE YJ , Li AJ, Walsh C, Karlan BY, et al
    Hormonal therapies demonstrate high response rates in treatment of recurrent uterine sarcomas.
    Gynecol Oncol. 2008;111:378.
    PubMed     Related articles   


  276. PAPADIA A , Azioni G, Nishida K, Seitz S, et al
    Frozen section is inaccurate at predicting need for staging in endometrial cancer.
    Gynecol Oncol. 2008;111:378-9.
    PubMed     Related articles   


  277. HOEKSTRA AV , Jairam-Thodla A, Berry E, Lurain JR, et al
    Effect of robotic surgery on a Gynecologic Oncology Fellowship Training Program.
    Gynecol Oncol. 2008;111:377.
    PubMed     Related articles   


  278. TYNDALL ML , Lowe MP, Johnson PR, Kamelle SA, et al
    Current utilization of robotic procedures by gynecologic oncologist: A multi-institutional retrospective review of outcomes.
    Gynecol Oncol. 2008;111:377-8.
    PubMed     Related articles   


  279. PAPADIA A , Schally AV, Seitz S, Buchholz S, et al
    Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues.
    Gynecol Oncol. 2008;111:376.
    PubMed     Related articles   


  280. NOURI-KINNEY S , Silva E, Walsh C, Li AJ, et al
    Distinguishing primary mucinous ovarian carcinomas from primary gastrointestinal carcinomas metastatic to the ovaries: Are we trying hard enough and does it matter?
    Gynecol Oncol. 2008;111:375.
    PubMed     Related articles   


  281. MCLEAN KA , Shah CA, Thompson SA, Gray HJ, et al
    Ovarian cancer in the elderly: Outcomes with neoadjuvant chemotherapy or primary cytoreduction.
    Gynecol Oncol. 2008;111:375-6.
    PubMed     Related articles   


  282. MCGONIGLE KF , Muntz HG, Vuky J, Paley PJ, et al
    Phase II prospective study of weekly topotecan and bevacizumab in platinum refractory ovarian or primary peritoneal cancer (OC).
    Gynecol Oncol. 2008;111:374.
    PubMed     Related articles   


  283. THOMAS SG , Judson PL, Carson LF, Downs LS Jr, et al
    Phase II trial of fulvestrant in the treatment of recurrent ovarian carcinoma.
    Gynecol Oncol. 2008;111:374-5.
    PubMed     Related articles   


  284. CHASE DM , Crade M, Basu T, Saffari B, et al
    Preoperative diagnosis of ovarian malignancy-preliminary results of the use of three-dimensional vascular ultrasound.
    Gynecol Oncol. 2008;111:373.
    PubMed     Related articles   


  285. BREWSTER WR
    The complexity of race in the disparate outcome and treatment of minority patients.
    Gynecol Oncol. 2008;111:161-2.
    PubMed     Related articles   


  286. HAMPL M , Hantschmann P, Michels W, Hillemanns P, et al
    Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany.
    Gynecol Oncol. 2008;111:282-8.
    PubMed     Related articles    Abstract available


  287. KEHOE SM , Eisenhauer EL, Chi DS
    Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy.
    Gynecol Oncol. 2008;111.
    PubMed     Related articles    Abstract available


  288. GROWDON WB , Boisvert SL, Akhavanfard S, Oliva E, et al
    Decreased survival in EGFR gene amplified vulvar carcinoma.
    Gynecol Oncol. 2008;111:289-97.
    PubMed     Related articles    Abstract available


  289. INSINGA RP , Ye X, Singhal PK, Carides GW, et al
    Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Gynecol Oncol. 2008;111:188-96.
    PubMed     Related articles    Abstract available


  290. CIBULA D , Slama J, Fischerova D
    Update on abdominal radical trachelectomy.
    Gynecol Oncol. 2008;111.
    PubMed     Related articles    Abstract available


  291. LIAN J , Dundas G, Carlone M, Ghosh S, et al
    Twenty-year review of radiotherapy for vaginal cancer: an institutional experience.
    Gynecol Oncol. 2008;111:298-306.
    PubMed     Related articles    Abstract available


  292. HORN LC , Hentschel B, Fischer U, Peter D, et al
    Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact.
    Gynecol Oncol. 2008;111:276-81.
    PubMed     Related articles    Abstract available


  293. SALEEMUDDIN A , Folkins AK, Garrett L, Garber J, et al
    Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.
    Gynecol Oncol. 2008;111:226-32.
    PubMed     Related articles    Abstract available


  294. BENEDETTI PANICI P , Bellati F, Plotti F, Di Donato V, et al
    Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma.
    Gynecol Oncol. 2008;111:307-11.
    PubMed     Related articles    Abstract available


    October 2008
  295. BRUN JL , Rouzier R, Darai E
    RE: External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  296. GATCLIFFE TA , Tewari KS, Shah A, Brewster WR, et al
    A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  297. MUGGIA F
    Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  298. KHUNAMORNPONG S , Settakorn J, Sukpan K, Srisomboon J, et al
    Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  299. HSIAO SM , Chen CA, Lin HH, Hsieh CY, et al
    Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox(R)) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  300. ADLEY BP , Gleason KJ, Yang XJ, Stack MS, et al
    Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  301. HELLBERG D , Tot T, Stendahl U
    Pitfalls in immunohistochemical validation of tumor marker expression - Exemplified in invasive cancer of the uterine cervix.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  302. ZHUGE Y , Lagman JA, Ansenberger K, Mahon CJ, et al
    CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  303. PALOMBA S , Falbo A, Mocciaro R, Russo T, et al
    Laparoscopic treatment for endometrial cancer: A meta-analysis of randomized controlled trials (RCTs).
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  304. EINSTEIN MH , Park KJ, Sonoda Y, Carter J, et al
    Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: A comparison of surgical and pathologic outcomes.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  305. RIMEL BJ , Huettner P, Powell MA, Mutch DG, et al
    Absence of MGMT promoter methylation in endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  306. MCMEEKIN DS , Walker JL, Hartenbach EM, Bookman MA, et al
    Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  307. FAN T , Zhao Q, Chen JJ, Chen WT, et al
    Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  308. RESNICK KE , Alder H, Hagan JP, Richardson DL, et al
    The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  309. SURI A , Frumovitz M, Milam MR, Dos Reis R, et al
    Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  310. MATHEWS C , Restivo A, Raker C, Weitzen S, et al
    Willingness of gynecologic cancer patients to participate in clinical trials.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  311. PLOTTI F , Zullo MA, Sansone M, Calcagno M, et al
    Post radical hysterectomy urinary incontinence: A prospective study of transurethral bulking agents injection.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  312. CHURA JC , Blomquist CH, Ryu HS, Argenta PA, et al
    Estrone sulfatase activity in patients with advanced ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  313. MALZONI M , Tinelli R, Cosentino F, Perone C, et al
    Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: A prospective randomized study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  314. ALETTI GD , Podratz KC, Cliby WA, Gostout BS, et al
    Stage IV ovarian cancer: Disease site-specific rationale for postoperative treatment.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  315. FOTOPOULOU C , Neumann U, Klapp C, Lichtenegger W, et al
    Long-term effects of neovaginal reconstruction with sigmoid loop technique on sexual function and self image in patients with gynecologic malignancies: Results of a prospective study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  316. ZIOLKOWSKA-SETA I , Madry R, Kraszewska E, Szymanska T, et al
    TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  317. SCHWAB KV , O'Malley DM, Fowler JM, Copeland LJ, et al
    Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  318. BRISTOW RE , Puri I, Chi DS
    Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  319. NEVADUNSKY NS , Barbieri JS, Kwong J, Merritt MA, et al
    RUNX3 protein is overexpressed in human epithelial ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  320. BLAND AE , Calingaert B, Secord AA, Lee PS, et al
    Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  321. BROOKS RA , Rader JS, Dehdashti F, Mutch DG, et al
    Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  322. MAZGANI M , Le N, Hoskins PJ
    Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer-the British Columbia Cancer Agency experience.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  323. COOSEMANS A , Moerman P, Verbist G, Maes W, et al
    Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  324. KO EM , Muto MG, Berkowitz RS, Feltmate CM, et al
    Robotic versus open radical hysterectomy: A comparative study at a single institution.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  325. FAGOTTI A , Francesco F, Giovanni S
    Re: "External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score"
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  326. BERKOWITZ RS , Goldstein DP
    Current management of gestational trophoblastic diseases.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  327. KIM K , Kang SB, Chung HH, Kim JW, et al
    XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  328. MOORE RG , McMeekin DS, Brown AK, Disilvestro P, et al
    A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  329. MANEO A , Chiari S, Bonazzi C, Mangioni C, et al
    Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  330. GREENWALD HP , McCorkle R, Fennie K
    Health status and adaptation among long-term cervical cancer survivors.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  331. HOFFMAN MS , Zervose E
    Colon resection for ovarian cancer: Intraoperative decisions.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  332. DOWDY SC , Aletti G, Cliby WA, Podratz KC, et al
    Extra-peritoneal laparoscopic para-aortic lymphadenectomy - A prospective cohort study of 293 patients with endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  333. DENARDIS SA , Holloway RW, Bigsby GE 4th, Pikaart DP, et al
    Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  334. SMITH-MCCUNE KK
    Human papillomavirus vaccine efficacy: aligning expectations with reality.
    Gynecol Oncol. 2008;111:1-2.
    PubMed     Related articles   


  335. GURROLA-DIAZ CM , Suarez-Rincon AE, Vazquez-Camacho G, Buonocunto-Vazquez G, et al
    P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
    Gynecol Oncol. 2008;111:120-4.
    PubMed     Related articles    Abstract available


  336. GONZALEZ-BOSQUET E , Esteva C, Munoz-Almagro C, Ferrer P, et al
    Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3).
    Gynecol Oncol. 2008;111:9-12.
    PubMed     Related articles    Abstract available


  337. TAMUSSINO K , Bader AA, Regauer S
    Do we need immunohistochemistry to evaluate sentinel lymph nodes in vulvar cancer?
    Gynecol Oncol. 2008;111:158.
    PubMed     Related articles   


    September 2008
  338. BELL MC , Torgerson J, Seshadri-Kreaden U, Suttle AW, et al
    Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  339. NOCI I , Pillozzi S, Lastraioli E, Dabizzi S, et al
    hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  340. ARANDA MA , McGory M, Sekeris E, Maggard M, et al
    Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer?
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  341. DARCY KM , Brady WE, McBroom JW, Bell JG, et al
    Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  342. HERZOG TJ , Powell MA, Rader JS, Gibb RK, et al
    Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  343. PAREJA F R , Ramirez PT, Borrero F M, Angel C G, et al
    Abdominal radical trachelectomy for invasive cervical cancer: A case series and literature review.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  344. RICHARDSON DL , Backes FJ, Seamon LG, Zanagnolo V, et al
    Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  345. SABBATINI P , Sill MW, O'Malley D, Adler L, et al
    A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  346. BAE JH , Lee SJ, Lee A, Park YG, et al
    Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  347. SORRENTINO A , Liu CG, Addario A, Peschle C, et al
    Role of microRNAs in drug-resistant ovarian cancer cells.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  348. TERPLAN M , Temkin S, Tergas A, Lengyel E, et al
    Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  349. STEFANIDIS K , Loutradis D, Vassiliou LV, Anastasiadou V, et al
    Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  350. HASHIMOTO H , Sudo T, Mikami Y, Otani M, et al
    Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  351. PALMA L , Marcus V, Gilbert L, Chong G, et al
    Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  352. FRUMOVITZ M , Soliman PT, Greer M, Schmeler KM, et al
    Laparoscopy training in gynecologic oncology fellowship programs.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  353. CHIVA L , Lapuente F, Gonzalez-Cortijo L, Carballo N, et al
    Sparing fertility in young patients with endometrial cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  354. LEVENBACK C
    Update on sentinel lymph node biopsy in gynecologic cancers.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  355. SOLOMON LA , Munkarah AR, Vorugu VR, Deppe G, et al
    Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  356. IGNATOV A , Bischoff J, Schwarzenau C, Krebs T, et al
    P16 alterations increase the metastatic potential of endometrial carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  357. TAKAI N , Ueda T, Nasu K, Narahara H, et al
    Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  358. BANSAL N , Herzog TJ, Brunner-Brown A, Wethington SL, et al
    The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  359. CARLSON JW , Stojadinovic A, Ennis W, Diegelmann R, et al
    Multidisciplinary panel discussion of a gynecologic oncology patient: Preventing wound complications.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  360. TANNER EJ , Zahurak ML, Bristow RE, Diaz-Montes TP, et al
    Surgical care of young women diagnosed with ovarian cancer: A population-based perspective.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  361. HARRY VN , Semple SI, Gilbert FJ, Parkin DE, et al
    Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  362. ZIVANOVIC O , Alektiar KM, Sonoda Y, Zhou Q, et al
    Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  363. UNGAR L , Palfalvi L, Novak Z
    Primary pelvic exenteration in cervical cancer patients.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  364. SHAFER A , Boggess JF
    Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci(R) surgical system.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  365. RICHARDSON DL , Seamon LG, Carlson MJ, O'Malley DM, et al
    CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  366. KOH WJ
    Early stage endometrial cancer: to radiate or not to radiate--that is the question.
    Gynecol Oncol. 2008;110:271-4.
    PubMed     Related articles   


  367. OBERMAIR A , Cheuk R, Pak SC, Perrin L, et al
    Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma.
    Gynecol Oncol. 2008;110:280-5.
    PubMed     Related articles    Abstract available


  368. PARK KJ , Soslow RA, Sonoda Y, Barakat RR, et al
    Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.
    Gynecol Oncol. 2008;110:316-23.
    PubMed     Related articles    Abstract available


  369. CHEN H , Liang C, Zhang L, Huang S, et al
    Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Gynecol Oncol. 2008;110:308-15.
    PubMed     Related articles    Abstract available


  370. SHERMAN JF , Mount SL, Evans MF, Skelly J, et al
    Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus.
    Gynecol Oncol. 2008;110:396-401.
    PubMed     Related articles    Abstract available


  371. JOHANN S , Klaeser B, Krause T, Mueller MD, et al
    Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer.
    Gynecol Oncol. 2008;110:324-8.
    PubMed     Related articles    Abstract available


  372. CASTELLSAGUE X
    Natural history and epidemiology of HPV infection and cervical cancer.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles    Abstract available



  373. Proceedings of the First Symposium on Cervical Cancer: challenging cervical cancer. Madrid, Spain. February 21-22, 2008.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles   


  374. BURKE TW
    The origins of multidisciplinary cancer care.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles   


  375. CARBALLO N , Gonzalez-Cortijo L, Gonzalez-Martin A, Rojo A, et al
    Indications for adjuvant radiotherapy treatment after surgery and novel modalities for treatment.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles    Abstract available


  376. GONZALEZ-CORTIJO L , Carballo N, Gonzalez-Martin A, Corraliza V, et al
    Novel chemotherapy approaches in chemoradiation protocols.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles    Abstract available


  377. RAMIREZ PT , Chiva LM
    The opportunity to share and exchange information with international colleagues was of paramount importance in further solidifying the bonds between our institutions. Introduction.
    Gynecol Oncol. 2008;110.
    PubMed     Related articles   


    August 2008
  378. NEZHAT F
    Minimally invasive surgery in gynecologic oncology: Laparoscopy versus robotics.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  379. FENG Q , Deftereos G, Hawes SE, Stern JE, et al
    DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  380. CARMO CC , Luiz RR, Silva G
    The effect of addition of chemotherapy to radiotherapy in the treatment of women with cervical cancer: A survival analysis using propensity score.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  381. GHAMANDE SA , Silverman MH, Huh W, Behbakht K, et al
    A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  382. ABU-RUSTUM NR , Khoury-Collado F, Gemignani ML
    Techniques of sentinel lymph node identification for early-stage cervical and uterine cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  383. DIAZ JP , Sonoda Y, Leitao MM, Zivanovic O, et al
    Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  384. MAKKER V , Abu-Rustum NR, Alektiar KM, Aghajanian CA, et al
    A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  385. JONSON AL , Rogers LM, Ramakrishnan S, Downs LS Jr, et al
    Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  386. LEITAO MM JR , Kehoe S, Barakat RR, Alektiar K, et al
    Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  387. FUJII S
    Anatomic identification of nerve-sparing radical hysterectomy: A step-by-step procedure.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  388. LOWE MP , Tillmanns T
    Outpatient laparoscopic extraperitoneal aortic nodal dissection for locally advanced cervical carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  389. ROB L , Pluta M, Strnad P, Hrehorcak M, et al
    A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  390. SANDERS MA , Gordinier M, Talwalkar SS, Moore GD, et al
    Embryonal rhabdomyosarcoma of the uterine cervix in a 41-year-old woman treated with radical hysterectomy and adjuvant chemotherapy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  391. CONNOR JP , Felder M
    Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  392. HAVRILESKY LJ , Sanders GD, Kulasingam S, Myers ER, et al
    Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  393. FERRANDINA G , Martinelli E, Petrillo M, Prisco MG, et al
    Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  394. KESTERSON JP , Mhawech-Fauceglia P, Lele S
    The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  395. ABU-RUSTUM NR , Neubauer N, Sonoda Y, Park KJ, et al
    Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  396. MARTINHO O , Goncalves A, Moreira MA, Ribeiro LF, et al
    KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  397. AHMED A , Zamba G, Degeest K, Lynch CF, et al
    The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  398. ROCCONI RP
    Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  399. WANG J , Zhang X, Ge X, Guo H, et al
    Proteomic studies of early-stage and advanced ovarian cancer patients.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  400. POWELL CB , Kneier A, Chen LM, Rubin M, et al
    A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  401. CICINELLI E , Marinaccio M, Barba B, Tinelli R, et al
    Reliability of diagnostic fluid hysteroscopy in the assessment of cervical invasion by endometrial carcinoma: A comparative study with transvaginal sonography and MRI.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  402. GEHRIG PA , Cantrell LA, Shafer A, Abaid LN, et al
    What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  403. BORONOW RC
    Endometrial cancer and lymph node surgery: the spins continue - A case for reason.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  404. DISTEFANO M , Riccardi S, Capelli G, Costantini B, et al
    Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  405. KIMBALL KJ , Numnum TM, Kirby TO, Zamboni WC, et al
    A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  406. LACOUR RA , Daniels MS, Westin SN, Meyer LA, et al
    What women with ovarian cancer think and know about genetic testing.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  407. ORBO A , Arnes M, Hancke C, Vereide AB, et al
    Treatment results of endometrial hyperplasia after prospective D-score classification A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  408. FADER AN , Edwards RP, Cost M, Kanbour-Shakir A, et al
    Sentinel lymph node biopsy in early-stage cervical cancer: Utility of intraoperative versus postoperative assessment.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  409. WOO MM , Salamanca CM, Symowicz J, Stack MS, et al
    SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  410. GERSHENSON DM
    SEER data: perspective at 10,000 feet.
    Gynecol Oncol. 2008;110:121-2.
    PubMed     Related articles   


  411. SHYLASREE TS , Karanjgaokar V, Tristram A, Wilkes AR, et al
    Contribution of demographic, psychological and disease-related factors to quality of life in women with high-grade vulval intraepithelial neoplasia.
    Gynecol Oncol. 2008;110:185-9.
    PubMed     Related articles    Abstract available


    July 2008
  412. GARCIA AA , Blessing JA, Nolte S, Mannel RS, et al
    A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  413. NEMANI D , Mitra N, Guo M, Lin L, et al
    Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  414. JIMENEZ DE LA PENA M , Martinez de Vega Fernandez V, Recio Rodriguez M, Carrascoso Arranz J, et al
    Current imaging modalities in the diagnosis of cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  415. JOVER R , Lourido D, Gonzalez C, Rojo A, et al
    Role of PET/CT in the evaluation of cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  416. CARTER J , Sonoda Y, Chi DS, Raviv L, et al
    Radical trachelectomy for cervical cancer: Postoperative physical andemotional adjustment concerns.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  417. ABU-RUSTUM NR , Chi DS, Leitao M, Oke EA, et al
    What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  418. KOIVISTO-KORANDER R , Ralf B, Koivisto AM, Leminen A, et al
    Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990-2001.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  419. SUTTON GP
    Endometrial stromal sarcomas-Clarification.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  420. KANG H , Kim TJ, Kim WY, Choi CH, et al
    Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  421. JENKINS D
    A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  422. PETRU E
    Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  423. EGLE D , Grissemann B, Zeimet AG, Muller-Holzner E, et al
    Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  424. SCHWARZ TF , Leo O
    Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  425. HARPER DM
    Impact of vaccination with Cervarixtrade mark on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  426. OLAWAIYE AB , Rauh-Hain JA, Withiam-Leitch M, Rueda B, et al
    Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  427. PAPADIMITRIOU CA , Fountzilas G, Bafaloukos D, Bozas G, et al
    Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: A Hellenic Co-operative Oncology Group (HeCOG) study.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  428. CHIVA LM , Lapuente F, Gonzalez-Cortijo L, Gonzalez-Martin A, et al
    Surgical treatment of recurrent cervical cancer: State of the art and new achievements.
    Gynecol Oncol. 2008.
    PubMed     Related articles   


  429. CROOG VJ , Abu-Rustum NR, Barakat RR, Alektiar KM, et al
    Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  430. OREZZOLI JP , Russell AH, Oliva E, Del Carmen MG, et al
    Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  431. RAMIREZ PT , Schmeler KM, Wolf JK, Brown J, et al
    Robotic radical parametrectomy and pelvic lymphadenectomy in patients with invasive cervical cancer.
    Gynecol Oncol. 2008.
    PubMed     Related articles    Abstract available


  432. TORNE A , Alonso I, Puig-Tintore LM, Pahisa J, et al
    Clinical role of cervical cancer vaccination: When and whom to vaccinate?
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  433. MCALPINE JN , Eisenkop SM, Spirtos NM
    Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  434. PERRONE AM , Casadio P, Formelli G, Levorato M, et al
    Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  435. QAMAR L , Davis R, Anwar A, Behbakht K, et al
    Protein kinase C inhibitor Go6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  436. URICK ME , Giles JR, Johnson PA
    VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  437. PUIG-TINTORE LM , Torne A, Alonso I
    Current techniques in screening for cervical cancer in Spain: Updated recommendations.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  438. RAJ MH , Abd Elmageed ZY, Zhou J, Gaur R, et al
    Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  439. AUERSPERG N , Woo MM, Gilks CB
    The origin of ovarian carcinomas: A developmental view.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  440. PECTASIDES D , Pectasides E, Papaxoinis G, Xiros N, et al
    Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: Clinical experience of a single institution.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  441. LLORET M , Lara PC, Bordon E, Rey A, et al
    MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  442. FUHRMAN CB , Kilgore J, LaCoursiere YD, Lee CM, et al
    Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition.
    Gynecol Oncol. 2008;110:93-8.
    PubMed     Related articles    Abstract available


  443. TAYLOR DD , Gercel-Taylor C
    MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
    Gynecol Oncol. 2008;110:13-21.
    PubMed     Related articles    Abstract available


  444. ORR J JR , Kelley J 3rd, Dizon D, Escobar P, et al
    Society of gynecologic oncologists position paper: breast cancer care.
    Gynecol Oncol. 2008;110:7-12.
    PubMed     Related articles   


  445. GOFF BA
    Quality measures in gynecologic cancers: what and when?
    Gynecol Oncol. 2008;110:3-4.
    PubMed     Related articles   


  446. SHIH KK , Levine DA
    Exosomal microRNAs step into the biomarker arena.
    Gynecol Oncol. 2008;110:1-2.
    PubMed     Related articles   


  447. TSILI AC , Tsampoulas C, Charisiadi A, Kalef-Ezra J, et al
    Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography.
    Gynecol Oncol. 2008;110:22-31.
    PubMed     Related articles    Abstract available


  448. YANG B , Pretorius RG, Belinson JL, Zhang X, et al
    False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3.
    Gynecol Oncol. 2008;110:32-6.
    PubMed     Related articles    Abstract available


  449. ROUZIER R , Preti M, Sideri M, Paniel BJ, et al
    A suggested modification to FIGO stage III vulvar cancer.
    Gynecol Oncol. 2008;110:83-6.
    PubMed     Related articles    Abstract available


  450. CARAWAY NP , Khanna A, Dawlett M, Guo M, et al
    Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
    Gynecol Oncol. 2008;110:37-42.
    PubMed     Related articles    Abstract available


    June 2008
  451. SALVADOR S , Rempel A, Soslow RA, Gilks B, et al
    Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  452. MORGAN MA , Darcy KM, Rose PG, Degeest K, et al
    Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  453. JOHNSON CC , Kessel B, Riley TL, Ragard LR, et al
    The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  454. MARKMAN M
    Mandating prospectively defined endpoints for ovarian cancer phase 2 trials: A strategy to improve the quality of gynecologic cancer clinical research.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  455. BAYAS JM , Costas L, Munoz A
    Cervical cancer vaccination indications, efficacy, and side effects.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  456. PARK JY , Kim DY, Suh DS, Kim JH, et al
    Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  457. GONZALEZ-MARTIN A , Gonzalez-Cortijo L, Carballo N, Garcia JF, et al
    The current role of neoadjuvant chemotherapy in the management of cervical carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  458. PAHISA J , Alonso I, Torne A
    Vaginal approaches to fertility-sparing surgery in invasive cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  459. HAVRILESKY LJ , Whitehead CM, Rubatt JM, Cheek RL, et al
    Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  460. COLEMAN RL
    The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: Current clinical trials.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  461. YAMAN C , Habelsberger A, Tews G, Polz W, et al
    The role of three-dimensional volume measurement in diagnosing endometrial cancer in patients with postmenopausal bleeding.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  462. BRUN JL , Rouzier R, Uzan S, Darai E, et al
    External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  463. YOSHIZAKI T , Enomoto T, Fujita M, Ueda Y, et al
    Frequent inactivation of RUNX3 in endometrial carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  464. KUMAR S , Shah JP, Bryant CS, Imudia AN, et al
    The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  465. LEFFERS N , Lambeck AJ, de Graeff P, Bijlsma AY, et al
    Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  466. HAMMES LS , Tekmal RR, Naud P, Edelweiss MI, et al
    Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  467. HAMILTON CA , Maxwell GL, Chernofsky MR, Bernstein SA, et al
    Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  468. RICHARDSON DL , Seamon LG, Cohn DE
    Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  469. PFAENDLER KS , Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, et al
    Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: Lessons from the field.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  470. KONNER J , Schilder RJ, Derosa FA, Gerst SR, et al
    A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  471. PRESS JZ , Kenyon JA, Xue H, Miller MA, et al
    Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  472. DEL CAMPO JM , Prat A, Gil-Moreno A, Perez J, et al
    Update on novel therapeutic agents for cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  473. CHAN KK , Tam KF, Tse KY, Ngan HY, et al
    The role of regular physical examination in the detection of ovarian cancer recurrence.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  474. KUMAR S , Morris RT, Malone JM Jr
    Relative mortality in the women over 60 years of age with cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  475. LEATH CA IIII , Decherd ME, Wilder JL
    Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  476. COHN DE , Hall NC, Povoski SP, Seamon LG, et al
    Novel perioperative imaging with (18)F-FDG PET/CT and intraoperative (18)F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  477. BEINER ME , Hauspy J, Rosen B, Murphy J, et al
    Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: A matched case-control study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  478. GOFF BA , Holmberg LA, Veljovich D, Kurland BF, et al
    Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan A phase II trial of the Puget Sound Oncology Consortium.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  479. KAJIYAMA H , Shibata K, Suzuki S, Ino K, et al
    Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  480. QU D , Qu H, Fu M, Zhao X, et al
    Increased expression of Nlp, a potential oncogene in ovarian cancer, and its implication in carcinogenesis.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  481. GIL-MORENO A , Diaz-Feijoo B, Perez-Benavente A, Del Campo JM, et al
    Impact of extraperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  482. KUOPPALA T , Maenpaa J, Tomas E, Puistola U, et al
    Surgically staged high-risk endometrial cancer: Randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  483. GIATROMANOLAKI A , Bates GJ, Koukourakis MI, Sivridis E, et al
    The presence of tumor-infiltrating FOXP3(+) lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  484. TAO X , Hu W, Ramirez PT, Kavanagh JJ, et al
    Chemotherapy for recurrent and metastatic cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  485. HENSLEY ML , Blessing JA, Mannel R, Rose PG, et al
    Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
    Gynecol Oncol. 2008;109:329-34.
    PubMed     Related articles    Abstract available


  486. FLEMING G
    Gemcitabine/docetaxel--welcome to a new standard.
    Gynecol Oncol. 2008;109:313-5.
    PubMed     Related articles   


  487. DORUM A , Tonstad S, Liavaag AH, Michelsen TM, et al
    Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2).
    Gynecol Oncol. 2008;109:377-83.
    PubMed     Related articles    Abstract available


  488. HAMPL M , Deckers-Figiel S, Hampl JA, Rein D, et al
    New aspects of vulvar cancer: changes in localization and age of onset.
    Gynecol Oncol. 2008;109:340-5.
    PubMed     Related articles    Abstract available


  489. THOMAS MB , Wright JD, Leiser AL, Chi DS, et al
    Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era.
    Gynecol Oncol. 2008;109:335-9.
    PubMed     Related articles    Abstract available


    May 2008
  490. AHN HJ , Bae J, Lee S, Ko JE, et al
    Differential expression of clusterin according to histological type of endometrial carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  491. PRETET JL , Jacquard AC, Saunier M, Clavel C, et al
    Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer The EDiTH III study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  492. GUDIPUDI DK , Hartzfeld K, Montemarano N, Del Priore G, et al
    Decreased breast cancer rates among women with choriocarcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  493. OFER L , Ofer G, Alon BA
    RE:"Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer"
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  494. DEVINE KM , Smicun Y, Hope JM, Fishman DA, et al
    S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  495. FRUMOVITZ M , Ramirez PT, Levenback CF
    Lymphatic mapping and sentinel lymph node detection in women with cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  496. ALBAREDA J , Herrera M, Lopez Salva A, Garcia Donas J, et al
    Sacral metastasis in a patient with endometrial cancer: Case report and review of the literature.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  497. RAMIREZ PT , Schmeler KM, Soliman PT, Frumovitz M, et al
    Fertility preservation in patients with early cervical cancer: Radical trachelectomy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  498. CHAO A , Ho KC, Wang CC, Cheng HH, et al
    Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  499. BOREN T , Xiong Y, Hakam A, Wenham R, et al
    MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  500. GOTLIEB WH , Saumet J, Beauchamp MC, Gu J, et al
    In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  501. MURDOCH WJ , Van Kirk EA, Isaak DD, Shen Y, et al
    Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  502. REN J , Peng Z, Yang K
    A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  503. MOORE RG , Brown AK, Miller MC, Badgwell D, et al
    Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  504. MOORE KN , Reid MS, Fong DN, Myers TK, et al
    Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  505. RAMIREZ PT , Soliman PT, Schmeler KM, Reis RD, et al
    Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  506. CARLSON JW , Kauderer J, Walker JL, Gold MA, et al
    A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  507. RAMIREZ PT , Schmeler KM, Milam MR, Slomovitz BM, et al
    Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  508. PAPADIMITRIOU CA , Bafaloukos D, Bozas G, Kalofonos H, et al
    Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Co-operative Oncology Group (HeCOG) study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  509. MILLER DS , Blessing JA, Bodurka DC, Bonebrake AJ, et al
    Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  510. GOFF BA
    Surgical education: what role should gynecologic oncologists play?
    Gynecol Oncol. 2008;109:164-5.
    PubMed     Related articles   


  511. BOYD J
    Whence epithelial ovarian carcinoma?
    Gynecol Oncol. 2008;109:161-3.
    PubMed     Related articles   


  512. BERIWAL S , Coon D, Heron DE, Kelley JL, et al
    Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
    Gynecol Oncol. 2008;109:291-5.
    PubMed     Related articles    Abstract available


  513. SAMAMA B , Schaeffer C, Boehm N
    P16 expression in relation to human papillomavirus in liquid-based cervical smears.
    Gynecol Oncol. 2008;109:285-90.
    PubMed     Related articles    Abstract available


  514. FOLKINS AK , Jarboe EA, Saleemuddin A, Lee Y, et al
    A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
    Gynecol Oncol. 2008;109:168-73.
    PubMed     Related articles    Abstract available


  515. RIEDINGER JM , Eche N, Basuyau JP, Dalifard I, et al
    Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study.
    Gynecol Oncol. 2008;109:194-8.
    PubMed     Related articles    Abstract available


  516. KOHORN E
    Comments concerning Professor Michael Seckl's response to Dr Kohorn's letter.
    Gynecol Oncol. 2008;109:309.
    PubMed     Related articles   


  517. KAFALI H
    HPV16 and increased risk of recurrence after treatment for CIN.
    Gynecol Oncol. 2008;109:309-10.
    PubMed     Related articles   


  518. HUH WK , Roden RB
    The future of vaccines for cervical cancer.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available


  519. DOWNS LS , Smith JS, Scarinci I, Flowers L, et al
    The disparity of cervical cancer in diverse populations.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available


  520. BAZE C , Monk BJ, Herzog TJ
    The impact of cervical cancer on quality of life: a personal account.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles   


  521. MONK BJ , Herzog TJ
    The new era of cervical cancer prevention: HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles   


  522. WRIGHT TC JR , Huh WK, Monk BJ, Smith JS, et al
    Age considerations when vaccinating against HPV.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available


  523. HERZOG TJ , Huh WK, Downs LS, Smith JS, et al
    Initial lessons learned in HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available


  524. MYERS E , Huh WK, Wright JD, Smith JS, et al
    The current and future role of screening in the era of HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available


    April 2008
  525. SINGH H , Jain M, Mittal B
    MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  526. QUIROS RM , Valianou M, Kwon Y, Brown KM, et al
    Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  527. BANSAL N , Herzog TJ, Burke W, Cohen CJ, et al
    The utility of preoperative endometrial sampling for the detection of uterine sarcomas.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  528. DURRANT D , Richards JE, Walker WT, Baker KA, et al
    Mechanism of cell death induced by cis-3, 4', 5-trimethoxy-3'-aminostilbene in ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  529. BAEK WS , Kubba SV
    Cauda equina syndrome due to leptomeningeal carcinomatosis of the ovary.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  530. WENZEL L , Huang HQ, Cella D, Walker JL, et al
    Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  531. NIMEIRI HS , Oza AM, Morgan RJ, Friberg G, et al
    Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortia.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  532. BULL PHELPS SL , Schorge JO, Peyton MJ, Shigematsu H, et al
    Implications of EGFR inhibition in ovarian cancer cell proliferation.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  533. WONG JY , Huggins GS, Debidda M, Munshi NC, et al
    Dichloroacetate induces apoptosis in endometrial cancer cells.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  534. MORRIS R , Alvarez RD, Andrews S, Malone J, et al
    Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  535. SUSUMU N , Sagae S, Udagawa Y
    Reply to Michael H.R. Eichbaum et al. "Adjuvant treatment of early-stage endometrial cancer: Which patient can benefit from chemotherapy?"
    Gynecol Oncol. 2008;.
    PubMed     Related articles   


  536. WRIGHT JD , Tian C, Mutch DG, Herzog TJ, et al
    Carboplatin dosing in obese women with ovarian cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  537. LEE HP , Seo SS, Ryu SY, Kim JH, et al
    Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  538. HARLEY I , Rosen B, Risch HA, Siminovitch K, et al
    Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  539. SANTILLAN A , Govan L, Zahurak ML, Diaz-Montes TP, et al
    Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  540. BRISTOW RE , Peiretti M, Zanagnolo V, Salani R, et al
    Transverse colectomy in ovarian cancer surgical cytoreduction: Operative technique and clinical outcome.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  541. KOTHARI R , Seamon L, Cohn D, Fowler J, et al
    Stage IV endometrial cancer after failed conservative management: A case report.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  542. CHAN JK , Teoh D, Hu JM, Shin JY, et al
    Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  543. PUCA R , Nardinocchi L, Pistritto G, D'Orazi G, et al
    Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  544. HENSLEY ML , Blessing JA, Degeest K, Abulafia O, et al
    Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


  545. YOUNG JL , Jazaeri AA, Darus CJ, Modesitt SC, et al
    Cyclooxygenase-2 in cervical neoplasia: a review.
    Gynecol Oncol. 2008;109:140-5.
    PubMed     Related articles    Abstract available


  546. QUERLEU D , Ferron G, Rafii A, Bouissou E, et al
    Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique.
    Gynecol Oncol. 2008;109:81-5.
    PubMed     Related articles    Abstract available


  547. FAMBRINI M , Penna C, Pieralli A, Bussani C, et al
    PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
    Gynecol Oncol. 2008;109:59-64.
    PubMed     Related articles    Abstract available


  548. MOORE RG , Robison K, Brown AK, DiSilvestro P, et al
    Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.
    Gynecol Oncol. 2008;109:65-70.
    PubMed     Related articles    Abstract available


  549. ORR JW JR , Naumann WR, Escobar P
    "Attitude is a little thing that makes a big difference" Winston Churchill.
    Gynecol Oncol. 2008;109:147-51.
    PubMed     Related articles   


  550. BARBERA L , Thomas G, Elit L, Covens A, et al
    Treating vulvar cancer in the new millennium: are patients receiving optimal care?
    Gynecol Oncol. 2008;109:71-5.
    PubMed     Related articles    Abstract available


  551. BENEDER C , Fuechsel FG, Krause T, Kuhn A, et al
    The role of 3D fusion imaging in sentinel lymphadenectomy for vulvar cancer.
    Gynecol Oncol. 2008;109:76-80.
    PubMed     Related articles    Abstract available


    November 2007
  552. AULT KA
    Human papillomavirus vaccines and the potential for cross-protection between related HPV types.
    Gynecol Oncol. 2007;107.
    PubMed     Related articles    Abstract available


  553. MATHIESEN O , Buus SK, Cramers M
    Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study.
    Gynecol Oncol. 2007;107:219-22.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: